 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 |
$ 9.85 |
2.66 % |
$ 637 M |
USA |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 5.12 |
3.75 % |
$ 820 M |
Britain |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
BioNTech SE
BNTX
|
35.7 |
$ 98.05 |
-5.22 % |
$ 27.2 B |
Germany |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
ACADIA Pharmaceuticals
ACAD
|
3.33 |
$ 21.95 |
-2.23 % |
$ 3.64 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
2.17 |
- |
- |
$ 96.9 B |
Britain |
 |
Cerus Corporation
CERS
|
2.12 |
$ 2.57 |
26.59 % |
$ 490 M |
USA |
 |
Berkeley Lights
BLI
|
1.49 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Calithera Biosciences
CALA
|
98.5 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
CymaBay Therapeutics
CBAY
|
110 |
- |
- |
$ 3.45 B |
USA |
 |
ChemoCentryx
CCXI
|
0.0564 |
- |
- |
$ 3.74 B |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Caladrius Biosciences
CLBS
|
3.58 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Cardiff Oncology
CRDF
|
196 |
$ 1.72 |
-0.87 % |
$ 115 M |
USA |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
7.34 |
- |
- |
$ 2.18 B |
USA |
 |
AIkido Pharma
AIKI
|
0.935 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
6.24 |
- |
- |
$ 2.02 B |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 2.91 |
-8.78 % |
$ 4.79 M |
Israel |
 |
Eiger BioPharmaceuticals
EIGR
|
0.197 |
- |
-9.21 % |
$ 2.55 M |
USA |
 |
Editas Medicine
EDIT
|
5.08 |
$ 2.9 |
-3.27 % |
$ 257 M |
USA |
 |
Edesa Biotech
EDSA
|
158 |
$ 18.92 |
3.53 % |
$ 60.5 M |
USA |
 |
Eloxx Pharmaceuticals
ELOX
|
48.8 |
- |
-5.68 % |
$ 8.28 M |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
Ampio Pharmaceuticals
AMPE
|
106 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Applied Therapeutics
APLT
|
54.1 |
- |
- |
$ 8.42 M |
USA |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Evogene Ltd.
EVGN
|
71.3 |
$ 0.78 |
- |
$ 27.9 M |
Israel |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |